Antisense And RNAi Therapeutics Market Size, Share & Trends Report

Antisense And RNAi Therapeutics Market Size, Share & Trends Analysis Report By Technology (RNA Interference, Antisense RNA), By Application (Ocular, Genetic), By Route of Administration (Intrathecal, Intravenous), By Region, And Segment Forecasts, 2024 - 2030

Report ID: 978-1-68038-805-3
Number of Pages: 130
Format: Electronic (PDF)

Historical Range: 2018 - 2023
Industry: Healthcare

Market Segmentation

Antisense & RNAi Therapeutics Technology Outlook (Revenue, USD Million, 2018 - 2030)
- RNA Interference
- Antisense RNA
Antisense & RNAi Therapeutics Application Outlook (Revenue, USD Million, 2018 - 2030)
- Ocular
- Cardiometabolic & Renal Disorders
- Cancer
- Respiratory Disorders
- Skin Diseases
- Neurodegenerative Disorders
- Genetic Disorders
- Infectious Diseases
Antisense & RNAi Therapeutics Route of Administration Outlook (Revenue, USD Million, 2018 - 2030)
- Intravenous Injections
- Intrathecal Injections
- Subcutaneous Injections
- Other Delivery Methods
Antisense & RNAi Therapeutics Regional Outlook (Revenue, USD Million, 2018 - 2030)
- North America
  - North America Antisense & RNAi Therapeutics Market, by Technology
    - RNA Interference
    - Antisense RNA
  - North America Antisense & RNAi Therapeutics Market, by Application
    - Ocular
    - Cardio metabolic & Renal Disorders
    - Respiratory Disorders
    - Skin Diseases
    - Cancer
    - Neurodegenerative Disorders
    - Genetic Disorders
    - Infectious Diseases
  - North America Antisense & RNAi Therapeutics Market, by Route of Administration
    - Intravenous Injections
    - Intrathecal Injections
    - Subcutaneous Injections
    - Other Delivery Methods
  - U.S.
    - U.S. Antisense & RNAi Therapeutics Market, by Technology
      - RNA Interference
      - Antisense RNA
    - U.S. Antisense & RNAi Therapeutics Market, by Application
      - Ocular
      - Cardio metabolic & Renal Disorders
      - Respiratory Disorders
      - Skin Diseases
      - Cancer
      - Neurodegenerative Disorders
      - Genetic Disorders
      - Infectious Diseases
    - U.S. Antisense & RNAi Therapeutics Market, by Route of Administration
      - Intravenous Injections
      - Intrathecal Injections
      - Subcutaneous Injections
      - Other Delivery Methods
  - Canada
    - Canada Antisense & RNAi Therapeutics Market, by Technology
      - RNA Interference
      - Antisense RNA
    - Canada Antisense & RNAi Therapeutics Market, by Application
      - Ocular
      - Cardio metabolic & Renal Disorders
      - Respiratory Disorders
      - Skin Diseases
      - Cancer
      - Neurodegenerative Disorders
      - Genetic Disorders
      - Infectious Diseases
    - Canada Antisense & RNAi Therapeutics Market, by Route of Administration
      - Intravenous Injections
      - Intrathecal Injections
      - Subcutaneous Injections
      - Other Delivery Methods
- Europe
  - Europe Antisense & RNAi Therapeutics Market, by Technology
    - RNA Interference
    - Antisense RNA
  - Europe Antisense & RNAi Therapeutics Market, by Application
    - Ocular
    - Cardio metabolic & Renal Disorders
    - Respiratory Disorders
    - Skin Diseases
    - Cancer
    - Neurodegenerative Disorders
    - Genetic Disorders
    - Infectious Diseases
  - Europe Antisense & RNAi Therapeutics Market, by Route of Administration
    - Intravenous Injections
    - Intrathecal Injections
    - Subcutaneous Injections
    - Other Delivery Methods
  - Germany
    - Germany Antisense & RNAi Therapeutics Market, by Technology
      - RNA Interference
      - Antisense RNA
    - Germany Antisense & RNAi Therapeutics Market, by Application
      - Ocular
      - Cardio metabolic & Renal Disorders
      - Respiratory Disorders
      - Skin Diseases
      - Cancer
      - Neurodegenerative Disorders
      - Genetic Disorders
      - Infectious Diseases
    - Germany Antisense & RNAi Therapeutics Market, by Route of Administration
      - Intravenous Injections
      - Intrathecal Injections
      - Subcutaneous Injections
      - Other Delivery Methods
  - UK
    - UK Antisense & RNAi Therapeutics Market, by Technology
      - RNA Interference
      - Antisense RNA
    - UK Antisense & RNAi Therapeutics Market, by Application
      - Ocular
      - Cardio metabolic & Renal Disorders
      - Respiratory Disorders
      - Skin Diseases
      - Cancer
      - Neurodegenerative Disorders
      - Genetic Disorders
      - Infectious Diseases
    - UK Antisense & RNAi Therapeutics Market, by Route of Administration
      - Intravenous Injections
      - Intrathecal Injections
      - Subcutaneous Injections
      - Other Delivery Methods
  - France
    - France Antisense & RNAi Therapeutics Market, by Technology
      - RNA Interference
      - Antisense RNA
    - France Antisense & RNAi Therapeutics Market, by Application
      - Ocular
      - Cardio metabolic & Renal Disorders
      - Respiratory Disorders
      - Skin Diseases
      - Cancer
      - Neurodegenerative Disorders
      - Genetic Disorders
      - Infectious Diseases
    - France Antisense & RNAi Therapeutics Market, by Route of Administration
      - Intravenous Injections
      - Intrathecal Injections
      - Subcutaneous Injections
      - Other Delivery Methods
  - Italy
    - Italy Antisense & RNAi Therapeutics Market, by Technology
      - RNA Interference
      - Antisense RNA
    - Italy Antisense & RNAi Therapeutics Market, by Application
      - Ocular
      - Cardio metabolic & Renal Disorders
      - Respiratory Disorders
      - Skin Diseases
      - Cancer
      - Neurodegenerative Disorders
      - Genetic Disorders
      - Infectious Diseases
    - Italy Antisense & RNAi Therapeutics Market, by Route of Administration
      - Intravenous Injections
      - Intrathecal Injections
      - Subcutaneous Injections
      - Other Delivery Methods
  - Spain
    - Spain Antisense & RNAi Therapeutics Market, by Technology
      - RNA Interference
      - Antisense RNA
    - Spain Antisense & RNAi Therapeutics Market, by Application
      - Ocular
      - Cardio metabolic & Renal Disorders
      - Respiratory Disorders
      - Skin Diseases
      - Cancer
      - Neurodegenerative Disorders
      - Genetic Disorders
      - Infectious Diseases
    - Spain Antisense & RNAi Therapeutics Market, by Route of Administration
      - Intravenous Injections
      - Intrathecal Injections
      - Subcutaneous Injections
      - Other Delivery Methods
  - Sweden
    - Sweden Antisense & RNAi Therapeutics Market, by Technology
      - RNA Interference
      - Antisense RNA
    - Sweden Antisense & RNAi Therapeutics Market, by Application
      - Ocular
      - Cardio metabolic & Renal Disorders
      - Respiratory Disorders
      - Cancer
      - Skin Diseases
      - Neurodegenerative Disorders
      - Genetic Disorders
      - Infectious Diseases
    - Sweden Antisense & RNAi Therapeutics Market, by Route of Administration
      - Intravenous Injections
      - Intrathecal Injections
      - Subcutaneous Injections
      - Other Delivery Methods
  - Denmark
    - Denmark Antisense & RNAi Therapeutics Market, by Technology
      - RNA Interference
      - Antisense RNA
    - Denmark Antisense & RNAi Therapeutics Market, by Application
      - Ocular
      - Cardio metabolic & Renal Disorders
      - Respiratory Disorders
      - Skin Diseases
      - Cancer
      - Neurodegenerative Disorders
      - Genetic Disorders
      - Infectious Diseases
    - Denmark Antisense & RNAi Therapeutics Market, by Route of Administration
      - Intravenous Injections
      - Intrathecal Injections
      - Subcutaneous Injections
      - Other Delivery Methods
  - Norway
    - Norway Antisense & RNAi Therapeutics Market, by Technology
      - RNA Interference
      - Antisense RNA
    - Norway Antisense & RNAi Therapeutics Market, by Application
      - Ocular
      - Cardio metabolic & Renal Disorders
      - Respiratory Disorders
      - Cancer
      - Skin Diseases
      - Neurodegenerative Disorders
      - Genetic Disorders
      - Infectious Diseases
    - Norway Antisense & RNAi Therapeutics Market, by Route of Administration
      - Intravenous Injections
      - Intrathecal Injections
      - Subcutaneous Injections
      - Other Delivery Methods
- Asia Pacific
  - Asia Pacific Antisense & RNAi Therapeutics Market, by Technology
    - RNA Interference
    - Antisense RNA
  - Asia Pacific Antisense & RNAi Therapeutics Market, by Application
    - Ocular
    - Cardio metabolic & Renal Disorders
    - Respiratory Disorders
    - Cancer
    - Skin Diseases
    - Neurodegenerative Disorders
    - Genetic Disorders
    - Infectious Diseases
  - Asia Pacific Antisense & RNAi Therapeutics Market, by Route of Administration
    - Intravenous Injections
    - Intrathecal Injections
    - Subcutaneous Injections
    - Other Delivery Methods
  - China
    - China Antisense & RNAi Therapeutics Market, by Technology
      - RNA Interference
      - Antisense RNA
    - China Antisense & RNAi Therapeutics Market, by Application
      - Ocular
      - Cardio metabolic & Renal Disorders
      - Respiratory Disorders
      - Skin Diseases
      - Neurodegenerative Disorders
      - Cancer
      - Genetic Disorders
      - Infectious Diseases
    - China Antisense & RNAi Therapeutics Market, by Route of Administration
      - Intravenous Injections
      - Intrathecal Injections
      - Subcutaneous Injections
      - Other Delivery Methods
  - Japan
    - Japan Antisense & RNAi Therapeutics Market, by Technology
      - RNA Interference
      - Antisense RNA
    - Japan Antisense & RNAi Therapeutics Market, by Application
      - Ocular
      - Cardiometabolic & Renal Disorders
      - Respiratory Disorders
      - Cancer
      - Skin Diseases
      - Neurodegenerative Disorders
      - Genetic Disorders
      - Infectious Diseases
    - Japan Antisense & RNAi Therapeutics Market, by Route of Administration
      - Intravenous Injections
      - Intrathecal Injections
      - Subcutaneous Injections
      - Other Delivery Methods
  - India
    - India Antisense & RNAi Therapeutics Market, by Technology
      - RNA Interference
      - Antisense RNA
    - India Antisense & RNAi Therapeutics Market, by Application
      - Ocular
      - Cardiometabolic & Renal Disorders
      - Respiratory Disorders
      - Skin Diseases
      - Cancer
      - Neurodegenerative Disorders
      - Genetic Disorders
      - Infectious Diseases
    - India Antisense & RNAi Therapeutics Market, by Route of Administration
      - Intravenous Injections
      - Intrathecal Injections
      - Subcutaneous Injections
      - Other Delivery Methods
  - South Korea
    - South Korea Antisense & RNAi Therapeutics Market, by Technology
      - RNA Interference
      - Antisense RNA
    - South Korea Antisense & RNAi Therapeutics Market, by Application
      - Ocular
      - Cardiometabolic & Renal Disorders
      - Cancer
      - Respiratory Disorders
      - Skin Diseases
      - Neurodegenerative Disorders
      - Genetic Disorders
      - Infectious Diseases
    - South Korea Antisense & RNAi Therapeutics Market, by Route of Administration
      - Intravenous Injections
      - Intrathecal Injections
      - Subcutaneous Injections
      - Other Delivery Methods
  - Australia
    - Australia Antisense & RNAi Therapeutics Market, by Technology
      - RNA Interference
      - Antisense RNA
    - Australia Antisense & RNAi Therapeutics Market, by Application
      - Ocular
      - Cardiometabolic & Renal Disorders
      - Cancer
      - Respiratory Disorders
      - Skin Diseases
      - Neurodegenerative Disorders
      - Genetic Disorders
      - Infectious Diseases
    - Australia Antisense & RNAi Therapeutics Market, by Route of Administration
      - Intravenous Injections
      - Intrathecal Injections
      - Subcutaneous Injections
      - Other Delivery Methods
  - Thailand
    - Thailand Antisense & RNAi Therapeutics Market, by Technology
      - RNA Interference
      - Antisense RNA
    - Thailand Antisense & RNAi Therapeutics Market, by Application
      - Ocular
      - Cardiometabolic & Renal Disorders
      - Cancer
      - Respiratory Disorders
      - Skin Diseases
      - Neurodegenerative Disorders
      - Genetic Disorders
      - Infectious Diseases
    - Thailand Antisense & RNAi Therapeutics Market, by Route of Administration
      - Intravenous Injections
      - Intrathecal Injections
      - Subcutaneous Injections
      - Other Delivery Methods
- Latin America
  - Latin America Antisense & RNAi Therapeutics Market, by Technology
    - RNA Interference
    - Antisense RNA
  - Latin America Antisense & RNAi Therapeutics Market, by Application
    - Ocular
    - Cardiometabolic & Renal Disorders
    - Cancer
    - Respiratory Disorders
    - Skin Diseases
    - Neurodegenerative Disorders
    - Genetic Disorders
    - Infectious Diseases
  - Latin America Antisense & RNAi Therapeutics Market, by Route of Administration
    - Intravenous Injections
    - Intrathecal Injections
    - Subcutaneous Injections
    - Other Delivery Methods
  - Brazil
    - Brazil Antisense & RNAi Therapeutics Market, by Technology
      - RNA Interference
      - Antisense RNA
    - Brazil Antisense & RNAi Therapeutics Market, by Application
      - Ocular
      - Cardiometabolic & Renal Disorders
      - Cancer
      - Respiratory Disorders
      - Skin Diseases
      - Neurodegenerative Disorders
      - Genetic Disorders
      - Infectious Diseases
    - Brazil Antisense & RNAi Therapeutics Market, by Route of Administration
      - Intravenous Injections
      - Intrathecal Injections
      - Subcutaneous Injections
      - Other Delivery Methods
  - Mexico
    - Mexico Antisense & RNAi Therapeutics Market, by Technology
      - RNA Interference
      - Antisense RNA
    - Mexico Antisense & RNAi Therapeutics Market, by Application
      - Ocular
      - Cardiometabolic & Renal Disorders
      - Respiratory Disorders
      - Cancer
      - Skin Diseases
      - Neurodegenerative Disorders
      - Genetic Disorders
      - Infectious Diseases
    - Mexico Antisense & RNAi Therapeutics Market, by Route of Administration
      - Intravenous Injections
      - Intrathecal Injections
      - Subcutaneous Injections
      - Other Delivery Methods
  - Argentina
    - Argentina Antisense & RNAi Therapeutics Market, by Technology
      - RNA Interference
      - Antisense RNA
    - Argentina Antisense & RNAi Therapeutics Market, by Application
      - Ocular
      - Cardiometabolic & Renal Disorders
      - Respiratory Disorders
      - Cancer
      - Skin Diseases
      - Neurodegenerative Disorders
      - Genetic Disorders
      - Infectious Diseases
    - Argentina Antisense & RNAi Therapeutics Market, by Route of Administration
      - Intravenous Injections
      - Intrathecal Injections
      - Subcutaneous Injections
      - Other Delivery Methods
- MEA
  - MEA Antisense & RNAi Therapeutics Market, by Technology
    - RNA Interference
    - Antisense RNA
  - MEA Antisense & RNAi Therapeutics Market, by Application
    - Ocular
    - Cardiometabolic & Renal Disorders
    - Respiratory Disorders
    - Skin Diseases
    - Cancer
    - Neurodegenerative Disorders
    - Genetic Disorders
    - Infectious Diseases
  - MEA Antisense & RNAi Therapeutics Market, by Route of Administration
    - Intravenous Injections
    - Intrathecal Injections
    - Subcutaneous Injections
    - Other Delivery Methods
  - South Africa
    - South Africa Antisense & RNAi Therapeutics Market, by Technology
      - RNA Interference
      - Antisense RNA
    - South Africa Antisense & RNAi Therapeutics Market, by Application
      - Ocular
      - Cardiometabolic & Renal Disorders
      - Respiratory Disorders
      - Cancer
      - Skin Diseases
      - Neurodegenerative Disorders
      - Genetic Disorders
      - Infectious Diseases
    - South Africa Antisense & RNAi Therapeutics Market, by Route of Administration
      - Intravenous Injections
      - Intrathecal Injections
      - Subcutaneous Injections
      - Other Delivery Methods
  - Saudi Arabia
    - Saudi Arabia Antisense & RNAi Therapeutics Market, by Technology
      - RNA Interference
      - Antisense RNA
    - Saudi Arabia Antisense & RNAi Therapeutics Market, by Application
      - Ocular
      - Cardiometabolic & Renal Disorders
      - Respiratory Disorders
      - Cancer
      - Skin Diseases
      - Neurodegenerative Disorders
      - Genetic Disorders
      - Infectious Diseases
    - Saudi Arabia Antisense & RNAi Therapeutics Market, by Route of Administration
      - Intravenous Injections
      - Intrathecal Injections
      - Subcutaneous Injections
      - Other Delivery Methods
  - UAE
    - UAE Antisense & RNAi Therapeutics Market, by Technology
      - RNA Interference
      - Antisense RNA
    - UAE Antisense & RNAi Therapeutics Market, by Application
      - Ocular
      - Cancer
      - Cardiometabolic & Renal Disorders
      - Respiratory Disorders
      - Skin Diseases
      - Neurodegenerative Disorders
      - Genetic Disorders
      - Infectious Diseases
    - UAE Antisense & RNAi Therapeutics Market, by Route of Administration
      - Intravenous Injections
      - Intrathecal Injections
      - Subcutaneous Injections
      - Other Delivery Methods

Report content

Qualitative Analysis

Industry overview
Industry trends
Market drivers and restraints
Market size
Growth prospects
Porter’s analysis
PESTEL analysis
Key market opportunities prioritized
Competitive landscape
- Company overview
- Financial performance
- Product benchmarking
- Latest strategic developments

Quantitative Analysis

Market size, estimates, and forecast from 2018 to 2030
Market estimates and forecast for product segments up to 2030
Regional market size and forecast for product segments up to 2030
Market estimates and forecast for application segments up to 2030
Regional market size and forecast for application segments up to 2030
Company financial performance

GET A FREE SAMPLE

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

Or view our licence options:

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

ESOMAR certified & member

ISO Certified

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.